arrow
P

Petrus Järvinen

university of helsinki
H指数:18
被引数:1,546

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

IDENTIFYING HIGHER RISK PATIENTS FOR URINARY TRACT INFECTION AFTER SHOCK WAVE LITHOTRIPSY: A SECONDARY ANALYSIS OF THE INTERNATIONAL APPEAL TRIAL

识别冲击波碎石术后尿路感染的高风险患者:国际APPEAL试验的二次分析

2026-05-010
PRE
Functionally Characterizing the Renal Cell Carcinoma Tumor-Immune Microenvironment via Patient-Derived Ex Vivo Models

通过患者来源的离体模型对肾细胞癌肿瘤免疫微环境进行功能表征

2026-02-010
PRE
Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC

肿瘤细胞FAP调控局部侵袭性ccRCC的EMT和免疫抑制

2026-01-010
PRE
A Multicenter Randomized Controlled Trial of Antimicrobial Prophylaxis to Prevent Urinary Tract Infections after Shockwave Lithotripsy for Urolithiasis: The APPEAL Trial

一项多中心随机对照试验,评估抗菌药物预防措施以预防肾结石碎石术后的尿路感染:APPEAL试验

2025-09-250
OAAI
Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma—An Observational Prospective Multicentre Diagnostic Test Cohort Study

尿糖胺聚糖评分用于监测中高危非转移性透明细胞肾细胞癌复发—一项前瞻性多中心诊断试验队列研究

2025-08-270
OAAI
Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses
2025-02-170
OAAI
Short- and long-term effects of imatinib in patients hospitalised for COVID-19: A randomised trial
2024-10-300
PRE
Practice Variation in the Management of Adult Hydroceles: A Multinational Survey

成人鞘膜积液管理中的实践差异:一项多国调查

2023-12-011
OAAI
Associations of PTEN and ERG with Magnetic Resonance Imaging Visibility and Assessment of Non-organ-confined Pathology and Biochemical Recurrence After Radical Prostatectomy
2021-11-019
OAAI
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids

表达增强的交叉杂交IgGA Fc PD-L1抑制剂的新型溶瘤腺病毒激活多种免疫效应子群体,从而在体外,体内和患者来源的肿瘤类器官中增强肿瘤杀伤

2021-08-0630
OAAI
The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium

组织学亚型对肾细胞癌患者术后复发的发生率,时间和模式的影响-RECUR Consortium的结果

2021-06-0138
PREAI
Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?

低危肾细胞癌患者在保留肾单位手术和根治性肾切除术后是否应该有不同的随访?

2021-04-266
OAAI